Company Filing History:
Years Active: 2010-2025
Title: Katharina Pock: Innovator in Coagulation Factor Research
Introduction
Katharina Pock is a distinguished inventor based in Wien, Austria. She has made significant contributions to the field of coagulation factor research, particularly in the development of high-purity preparations and processes.
Latest Patents
Katharina holds 2 patents that showcase her innovative work. Her latest patents include the "FX activation process and its use in the preparation of a FXa composition," which relates to a high purity Coagulation Factor Xa (FXa) preparation. This invention details an activation and purification process to obtain FXa of high purity and high degree of activation without the addition of proteinaceous activators during manufacturing. Another notable patent is the "Prekallikrein depleted plasma derived albumin fraction," which describes an albumin-containing fraction with reduced prekallikrein activator (PKA) content and outlines a method for its manufacturing.
Career Highlights
Katharina Pock is currently associated with Octapharma AG, a company known for its focus on human proteins for the treatment of various medical conditions. Her work at Octapharma AG has been pivotal in advancing the understanding and application of coagulation factors.
Collaborations
Throughout her career, Katharina has collaborated with notable professionals in her field, including Werner Gehringer and Juergen Roland Roemisch. These collaborations have further enriched her research and innovations.
Conclusion
Katharina Pock is a remarkable inventor whose work in coagulation factor research has led to significant advancements in medical science. Her contributions continue to impact the field positively.